BioCentury
ARTICLE | Clinical News

VicOryx: Phase I started

September 21, 2015 7:00 AM UTC

Oryx began the open-label, German Phase I VICORYX-2 trial to evaluate 100 ug subcutaneous VicOryx with the Montanide ISA-51 VG adjuvant in combination with cisplatin-based chemotherapy in 10 patients ...